The regulatory effects and applications of TIGIT/CD155 on the tumor microenvironment in HCC

Abstract Hepatocellular carcinoma (HCC) is the most commonly occurring liver cancer, and poses a significant burden on individuals, society, the economy, and the healthcare system. Despite advancements in therapeutic options such as surgical interventions and targeted therapies, the complex etiology...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Wenting Li, Yukun Li, Yao Li, Mingqi Yang, Haichuan Peng, Hongwei Sun, Ping Jiang, Yizhun Zhu, Qiang Chen, Xiaobing Duan, Wei Zhao
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-10-01
Edice:	View
Témata:	CD155 hepatocellular carcinoma immune checkpoint inhibitor TIGIT
On-line přístup:	https://doi.org/10.1002/VIW.20240071
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!